Article
Molecular assays for antimalarial drug resistance surveillance: A target product profile
20 Sept 2018
Abstract excerpt
Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong Sub region and may emerge or spread to other malaria endemic regions. This spread is of great concern for malaria...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
